NEW YORK (GenomeWeb) – PerkinElmer said after the close of the market on Wednesday that its third quarter revenues grew 22 percent year over year, paced by its diagnostics segment, which was up 59 percent.

For the three months ended Sept. 30, the company reported total revenues of $674.3 million, up from $554.3 million a year ago, but short of the consensus Wall Street estimate of $676.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.